Avoro Capital Advisors LLC Q4 2020 Filing
Filed February 16, 2021
Portfolio Value
$5.8T
Holdings
44
Report Date
Q4 2020
Filing Type
13F-HR
All Holdings (44 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | MRTXEURMIRATI THERAPEUTICS INC | 4,535,000 | $996.1B | 17.15% | |
| 2 | HZNPHORIZON THERAPEUTICS PLC | 9,000,000 | $658.4B | 11.34% | |
| 3 | UTHUNITED THERAPEUTICS CORP | 2,850,000 | $432.6B | 7.45% | |
| 4 | IOVAIOVANCE BIOTHERAPEUTICS INC | 7,500,000 | $348.0B | 5.99% | |
| 5 | ARNAEURARENA PHARMACEUTICALS INC | 4,190,000 | $321.9B | 5.54% | |
| 6 | ASNDASCENDIS PHARMA | 1,800,000 | $300.2B | 5.17% | |
| 7 | SRPTSAREPTA THERAPEUTICS INC | 1,750,000 | $298.4B | 5.14% | |
| 8 | ARGXARGENX SE | 902,500 | $265.4B | 4.57% | |
| 9 | AM6AMICUS THERAPEUTICS INC | 9,000,000 | $207.8B | 3.58% | |
| 10 | XLRNACCELERON PHARMA INC | 1,550,000 | $198.3B | 3.42% | |
| 11 | —MERSANA THERAPEUTICS INC | 6,800,000 | $180.9B | 3.12% | |
| 12 | BMRNBIOMARIN PHARMACEUTICAL INC | 1,650,000 | $144.7B | 2.49% | |
| 13 | MDGLMADRIGAL PHARMACEUTICALS INC | 1,225,000 | $136.2B | 2.35% | |
| 14 | KURAKURA ONCOLOGY INC | 4,000,000 | $130.6B | 2.25% | |
| 15 | PMVPPMV PHARMACEUTICALS INC | 2,350,267 | $130.5B | 2.25% | |
| 16 | ACADACADIA PHARMACEUTICALS INC | 1,950,000 | $104.2B | 1.80% | |
| 17 | ADVMCHFADVERUM BIOTECHNOLOGIES INC | 8,000,000 | $86.7B | 1.49% | |
| 18 | TREURTRILLIUM THERAPEUTICS INC | 5,800,000 | $85.3B | 1.47% | |
| 19 | —CONSTELLATION PHARMACEUTICALS INC | 2,950,000 | $85.0B | 1.46% | |
| 20 | DCPHEURDECIPHERA PHARMACEUTICALS INC | 1,300,000 | $74.2B | 1.28% | |
| 21 | PRAXPRAXIS PRECISION MEDICINES INC | 1,545,495 | $68.7B | 1.18% | |
| 22 | CBAYUSDCYMABAY THERAPEUTICS INC | 10,300,000 | $59.1B | 1.02% | |
| 23 | OPHTEURIVERIC BIO INC | 7,250,000 | $50.1B | 0.86% | |
| 24 | TVTXTRAVERE THERAPEUTICS INC | 1,800,500 | $49.1B | 0.85% | |
| 25 | RLMDRELMADA THERAPEUTICS INC | 1,525,000 | $48.9B | 0.84% | |
| 26 | XENEXENON PHARMACEUTICALS INC | 2,800,000 | $43.1B | 0.74% | |
| 27 | MRNS*MARINUS PHARMACEUTICALS INC | 3,232,142 | $39.4B | 0.68% | |
| 28 | OLMAOLEMA PHARMACEUTICALS INC | 876,986 | $35.6B | 0.61% | |
| 29 | AMRNAMARIN CORP PLC | 6,000,000 | $29.3B | 0.51% | |
| 30 | AVDLAVADEL PHARMACEUTICALS PLC | 4,365,000 | $29.2B | 0.50% | |
| 31 | RLAYRELAY THERAPEUTICS INC | 500,000 | $20.8B | 0.36% | |
| 32 | BDTXBLACK DIAMOND THERAPEUTICS INC | 640,000 | $20.5B | 0.35% | |
| 33 | ADAPYADAPTIMMUNE THERAPEUTICS PLC | 3,550,000 | $19.1B | 0.33% | |
| 34 | 5E7ITEOS THERAPEUTICS INC | 460,000 | $15.6B | 0.27% | |
| 35 | —THERAPEUTICS ACQUISITION CORP | 1,000,000 | $13.9B | 0.24% | |
| 36 | RNAAVIDITY BIOSCIENCES INC | 545,000 | $13.9B | 0.24% | |
| 37 | FRXFENNEC PHARMACEUTICALS INC | 1,670,000 | $12.4B | 0.21% | |
| 38 | GNCAQGENOCEA BIOSCIENCES INC | 5,084,184 | $12.3B | 0.21% | |
| 39 | MNKDMANNKIND CORP | 3,500,000 | $11.0B | 0.19% | |
| 40 | SNDXSYNDAX PHARMACEUTICALS INC | 450,000 | $10.0B | 0.17% | |
| 41 | —BCTG ACQUISITION CORP | 800,000 | $9.2B | 0.16% | |
| 42 | CUECUE BIOPHARMA INC | 452,500 | $5.7B | 0.10% | |
| 43 | ATNXEURATHENEX INC | 372,500 | $4.1B | 0.07% | |
| 44 | NKTREURNEKTAR THERAPEUTICS | 100,000 | $26.0M | 0.00% | Call |